Atlas Trials

Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment

Clinical trial NCT03937908 · TERMINATED

Trial details

NCT number
NCT03937908
Sponsor
Oregon Health and Science University
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cognitive ImpairmentElderly
Start date
2019-10-31
Primary completion
2020-12-21
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.